Article

Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes

2022-06-30

Abstract excerpt

Following the breakthrough of immune check point inhibitors (ICIs), a new era of immuno-oncology agents has emerged and established immunotherapy as a part of cancer treatment. Despite the improving outcomes of ICIs, many patients with initial response are known to develop acquired resistance later. There is increasing interest in utilizing other stimulatory means, such as anti-pathogen immune responses to induce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c0010ecb-1a1d-50de-89c5-af5aba605165
DOI: 10.1101/2022.06.30.498305

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer OutcomesDOI 10.1101/2022.06.30.498305Read

COVID-19 Vaccines: Bolstering Cancer TreatmentSemantic proximity Read

Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV.Semantic proximity Read

Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1Semantic proximity Read

Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.Semantic proximity Read

Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in miceSemantic proximity Read

Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical TherapiesSemantic proximity Read

Elucidating Mechanisms of Antitumor Immunity Mediated by Live Oncolytic Vaccinia and Heat-Inactivated VacciniaSemantic proximity Read

Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor modelsSemantic proximity Read

The oncolytic virus ΔPK has multimodal anti-tumor activity.Semantic proximity Read

Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity.Semantic proximity Read

Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor resistant tumors resulting in complete responsesSemantic proximity Read

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumorsSemantic proximity Read